Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
New treatments for methicillin-resistant Staphylococcus aureus
Current Opinion in Critical Care, 09/14/09
Stryjewski ME et al. – Linezolid, daptomycin and tigecycline have been approved during the last decade to treat infections due to MRSA. Although these agents are extremely valuable in the fight against MRSA, each one has limitations. New lypoglycopeptides (telavancin, dalbavancin and oritavancin) are in advanced phase of clinical development. Similarly, new broad–spectrum cephalosporins active against MRSA (e.g. ceftobiprole and ceftaroline) and a new dihydrofolate reductase inhibitor (iclaprim) are in or have completed phase 3 studies.
Related Articles
Implementation of a methicillin-resistant Staphylococcus aureus (MRSA) prevention bundle results in decreased MRSA surgical site infections
The American Journal of Surgery, 11/03/09
Relevance Score: 93%
Twenty-five year epidemiology of invasive methicillin-resistant Staphylococcus aureus (MRSA) isolates recovered at a burn center
Burns, 11/16/09
Relevance Score: 89%
Bench-to-bedside review: Understanding the impact of resistance and virulence factors on MRSA infections in the ICU
Critical Care, 10/27/09
Relevance Score: 88%
Clinical Importance of Purulence in Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections
Journal of the American Board of Family Medicine, 11/09/09
Relevance Score: 87%
Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland
BMJ - Archives of Diseases in Childhood, 10/29/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Propylene Glycol Accumulation in Critically Ill Patients Receiving Continuous Intravenous Lorazepam Infusions
Annals of Pharmacotherapy, 11/25/09
Pharmacotherapy for acute pancreatitis
Expert Opinion in Pharmacotherapy, 11/24/09
Ascorbic Acid Potentiation of Arsenic Trioxide Anticancer Activity Against Acute Promyelocytic Leukemia
Archives of Drug Information, 11/24/09
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Emergency Influenza Drug
JAMA, 11/25/09
Emerging Role of Candida in Deep Sternal Wound Infection
Annals of Thoracic Surgery, 11/25/09
Will Routine Annual Influenza Prevention and Control Systems Serve the United States Well in a Pandemic
Disaster Medicine and Public Health Preparedness, 11/25/09
Article Search
Sponsor


See Latest Articles


